Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial

Fulltext:
248179.pdf
Embargo:
until further notice
Size:
1.030Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2022Source
The Lancet (London), 399, 10329, (2022), pp. 1059-1069ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Neurology
Medical Imaging
Internal Medicine
Journal title
The Lancet (London)
Volume
vol. 399
Issue
iss. 10329
Page start
p. 1059
Page end
p. 1069
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 0: Other Research RIHS: Radboud Institute for Health Sciences; Radboudumc 16: Vascular damage RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [229074]
- Electronic publications [111477]
- Faculty of Medical Sciences [87745]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.